The treatment of glenohumeral arthritis in a young patient poses a significant challenge. Factors that affect decision making include higher activity levels, greater expectations, and concerns of implant longevity. Conflicting results have been reported in the literature. The purpose of this study is to report on our results for resurfacing of the humeral head combined with a biologic glenoid resurfacing using a soft tissue allograft for the treatment of glenohumeral osteoarthritis. From 2003 to 2009 a retrospective multi-center review of 15 humeral and biologic glenoid resurfacing procedures with a mean age of 36.5 yrs. was performed. Indications for surgery included a diagnosis of glenohumeral arthritis non-responsive to conservative treatment. Exclusion criteria included major glenoid osseous deficiency, advanced rheumatoid arthritis, and chronic infection.Introduction
Methods
